MDT · Medtronic plc
$86.632026-05-17Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Very High Uncertainty
Base · active
$83
-4.2% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($1 · $92) Analysts Range ($100 · $120) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2022.Q3 | $30.1B | — | 16.3% | 10.0% | $4.4B | −$592MM | $3.8B | 4.9% | — | 6.0% | $73.8B | $2.80 | — |
| 2023.Q3 | $31.7B | 5.2% | 19.9% | 24.5% | $4.8B | −$2.6B | $2.1B | 6.9% | — | 6.3% | $76.6B | $3.91 | — |
| 2024.Q3 | $31.2B | -1.4% | 19.2% | 23.5% | $4.6B | −$381MM | $4.2B | 6.8% | — | 6.0% | $76.6B | $2.92 | — |
| 2025.Q3 | $32.4B | 3.6% | 17.4% | 17.9% | $4.6B | $1.4B | $6.0B | 7.9% | — | 6.0% | $76.2B | $2.85 | — |
| 2026.Q3 | $35.5B | 9.6% | 19.5% | 16.6% | $5.8B | −$751MM | $5.0B | 7.4% | — | 7.6% | $76.8B | $3.58 | 16.1 |
| italics below = DCF projection · 10yr Rev CAGR: 5.3% |
| 2027.Q3 | $38.1B | +7.5% | 19.4% | 16.9% | $6.2B | −$576MM | $5.6B | 7.5% | $5.2B | 8.0% | $77.3B | $4.37 | 19.8 |
| 2028.Q3 | $40.2B | +5.5% | 19.7% | 17.3% | $6.5B | −$654MM | $5.9B | 7.6% | $5.1B | 8.4% | $78.0B | $4.64 | 18.7 |
| 2029.Q3 | $42.7B | +6.2% | 20.2% | 17.6% | $7.1B | −$1.4B | $5.8B | 7.7% | $4.6B | 9.1% | $79.3B | $5.05 | 17.2 |
| 2030.Q3 | $45.1B | +5.5% | 20.9% | 18.0% | $7.7B | $0MM | $7.7B | 7.8% | $5.7B | 9.7% | $79.3B | $5.48 | 15.8 |
| 2031.Q3 | $47.5B | +5.3% | 20.9% | 18.3% | $8.1B | $0MM | $8.1B | 8.0% | $5.6B | 10.2% | $79.3B | $5.75 | 15.1 |
|
| Term. Yr+ | $61.8B | 4.1% | 19.4% | 20.0% | $9.6B | −$3.0B | $6.6B | 8.6% | $67.9B | 13.1% | — | — | — |
Active scenario IV: $83 (-4.2% vs market)